You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for New Drug Application (NDA): 022335


✉ Email this page to a colleague

« Back to Dashboard


NDA 022335 describes TECHNEGAS KIT, which is a drug marketed by Cyclomedica and is included in one NDA. It is available from one supplier. Additional details are available on the TECHNEGAS KIT profile page.

The generic ingredient in TECHNEGAS KIT is technetium tc-99m labeled carbon. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m labeled carbon profile page.
Summary for 022335
Tradename:TECHNEGAS KIT
Applicant:Cyclomedica
Ingredient:technetium tc-99m labeled carbon
Patents:0
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 022335
Generic Entry Date for 022335*:
Constraining patent/regulatory exclusivity:
NEW PRODUCT
Dosage:
AEROSOL;INHALATION

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Suppliers and Packaging for NDA: 022335
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TECHNEGAS KIT technetium tc-99m labeled carbon AEROSOL;INHALATION 022335 NDA Cyclomedica Australia Pty Limited 73814-987 73814-987-20 1 KIT in 1 CARTON (73814-987-20) * 1 in 1 CARTON (GS1:19340598000050) * 50 AEROSOL in 1 CARTON (73814-986-20)
TECHNEGAS KIT technetium tc-99m labeled carbon AEROSOL;INHALATION 022335 NDA Cyclomedica Australia Pty Limited 73814-989 73814-989-20 1 KIT in 1 CARTON (73814-989-20) * 50 AEROSOL in 1 CARTON (73814-986-20) * 50 in 1 CARTON (GS1:19340598000036)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL;INHALATIONStrengthN/A
Approval Date:Sep 29, 2023TE:RLD:Yes
Regulatory Exclusivity Expiration:Sep 29, 2026
Regulatory Exclusivity Use:NEW PRODUCT

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.